Federal contractor profile

4J THERAPEUTICS INC

UEI SZCGV7LQJKR4CAGE 9DFF0

Active

Small Business

Overview

Legal name: 4J THERAPEUTICS INC
Registered location: PALO ALTO, CA, USA
Primary NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Latest award activity: Aug 21, 2026

Read company summary

4J THERAPEUTICS INC is associated with UEI SZCGV7LQJKR4 and CAGE 9DFF0 in public federal records. AcornBids currently links 1 prime award totaling $52.5M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists PALO ALTO, CA, USA.

At a glance

Lifetime prime obligations$52.5M

Prime awards1

Awards with future end dates1

Top-agency concentration100.0%

Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.

Business information

Public SAM.gov registration details.

Legal name: 4J THERAPEUTICS INC
UEI: SZCGV7LQJKR4
CAGE: 9DFF0
Registered address: 965 CLARK WAY, PALO ALTO, CA, 94304, USA
Registration status: Active
Primary NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
SAM activation: Apr 9, 2026
Initial registration: Sep 7, 2022
Entity start: Aug 9, 2022
SAM updated: Apr 9, 2026
Registration expires: Apr 7, 2027
Fiscal year end: Dec 31
Place of incorporation: DE, USA

View SAM.gov source

Federal award analysis

Net transaction obligations by federal fiscal period.

Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.

Recent federal awards

Prime contract awards. Select an award to review its history and source evidence.

Award / description	Awarding agency	Obligations	Start date	End date
75A50124C00052THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO DEMONSTRATE THE VERSATILITY AND EFFICACY OF OUR PROGRAMMABLE ANTIVIRAL TECHNOLOGY PLATFORM BY ASSEMBLING THE PRECLINICAL PACKAGE FOR…	Department of Health and Human Services	$52.5M	Sep 30, 2024	Jun 30, 2032

Explore, filter and export all awards →Subcontracts Grants & subgrants

Upcoming positioning windows

Modeled recompete windows are estimates, not announced solicitations or guarantees.

THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO DEMONSTRATE THE VERSATILITY AND EFFICACY OF OUR PROGRAMMABLE ANTIVIRAL TECHNOLOGY PLATFORM BY ASSEMBLING THE PRECLINICAL PACKAGE FOR…

Department of Health and Human Services$52.5M obligationsEnds Jun 30, 203250% recompete estimate

Registration, certifications & contacts

Registration evidence	Date
SAM updated	Apr 9, 2026
Source loaded	Sep 26, 2026
Initial registration	Sep 7, 2022
Entity start	Aug 9, 2022

Registration classifications: Small Business. These are separate from the reported certificates above.

Industry	Reported size status
541714 — Research and Development in Biotechnology (except Nanobiotechnology)	Not reported

Contact	Role	Published contact methods	Evidence	Source date
RACHEL H SALUTI	Government business	Contact method not published	SAM registration	Not available
MENASHE ELAZAR	Electronic business	Contact method not published	SAM registration	Not available

Registered industries

541714 — Research and Development in Biotechnology (except Nanobiotechnology)

Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source